Dana Investment Advisors Inc. Sells 5,758 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Dana Investment Advisors Inc. decreased its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 5.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 99,631 shares of the company’s stock after selling 5,758 shares during the period. Dana Investment Advisors Inc.’s holdings in Prestige Consumer Healthcare were worth $7,780,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC increased its holdings in shares of Prestige Consumer Healthcare by 3.1% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company’s stock worth $126,274,000 after purchasing an additional 49,331 shares during the period. Geode Capital Management LLC grew its position in Prestige Consumer Healthcare by 4.0% during the third quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock worth $95,678,000 after buying an additional 50,961 shares in the last quarter. Congress Asset Management Co. increased its stake in Prestige Consumer Healthcare by 5.0% during the 4th quarter. Congress Asset Management Co. now owns 908,742 shares of the company’s stock worth $70,964,000 after acquiring an additional 43,619 shares during the period. Boston Trust Walden Corp raised its holdings in Prestige Consumer Healthcare by 43.5% in the 4th quarter. Boston Trust Walden Corp now owns 831,627 shares of the company’s stock valued at $64,942,000 after acquiring an additional 252,089 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Prestige Consumer Healthcare by 5.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company’s stock valued at $49,667,000 after acquiring an additional 33,844 shares during the period. Institutional investors own 99.95% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently commented on PBH. DA Davidson raised their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Sidoti cut shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price for the company. in a research report on Monday, December 9th. Oppenheimer upped their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday, February 13th. Finally, Canaccord Genuity Group lifted their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $92.60.

Prestige Consumer Healthcare Stock Up 1.7 %

Shares of NYSE PBH opened at $85.67 on Thursday. The company has a market cap of $4.24 billion, a price-to-earnings ratio of 20.06, a PEG ratio of 2.69 and a beta of 0.50. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a 12 month low of $62.35 and a 12 month high of $88.36. The stock has a 50-day moving average price of $80.43 and a two-hundred day moving average price of $77.57.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. As a group, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.